INTANGIBLE ASSETS AND GOODWILL (Details 2) (USD $)	12 Months Ended				3 Months Ended	12 Months Ended	3 Months Ended		12 Months Ended	3 Months Ended		12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013 Ezogabine Retigabine	Sep. 30, 2013 Ezogabine Retigabine Developed Markets	Dec. 31, 2013 Opana	Sep. 30, 2013 Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Ezogabine Retigabine	Sep. 30, 2013 Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Ezogabine Retigabine Developed Markets	Dec. 31, 2013 Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Ezogabine Retigabine Developed Markets	Mar. 31, 2013 Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Opana Developed Markets	Sep. 30, 2013 Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Discontinued OTC Skincare Developed Markets	Dec. 31, 2013 Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Discontinued OTC Skincare Developed Markets	Dec. 31, 2013 Australia Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Discontinued OTC Skincare Developed Markets	Dec. 31, 2013 Brazilian, Canadian, and Polish Markets Amortization and Impairments of Finite-lived Intangible Assets Non-recurring basis Discontinued OTC Skincare Developed Markets
Intangible assets
Impairment charges on intangible assets				$ 551,600,000	$ 551,600,000	$ 22,200,000	$ 551,600,000	$ 551,600,000	$ 551,600,000	$ 22,200,000	$ 10,000,000	$ 10,000,000	$ 31,500,000	$ 38,000,000
Amortization expense related to intangible assets recorded as follows:
Alliance and royalty revenue		0	1,072,000
Cost of goods sold	0	2,557,000	8,103,000
Amortization and impairments of finite-lived intangible assets	1,901,977,000	928,885,000	557,814,000
Total amortization of intangible assets	1,901,977,000	931,442,000	566,989,000
Estimated aggregate amortization expense
2014	1,406,660,000
2015	1,368,548,000
2016	1,278,275,000
2017	1,213,345,000
2018	$ 1,088,496,000